Catalyst Biosciences, Inc. (NASDAQ: CBIO), announced today that it will be hosting a Key Opinion Leader (KOL) Subcutaneous Factor VIIa (FVIIa) ...
Tuesday, 13 August 2019
Catalyst Biosciences is Hosting KOL Meeting on Subcutaneous Factor-VIIa Marzeptacog Alfa (Activated) in Bleeding Disorders Patients on 15 August - BіоPhаrmа Dіvе
Catalyst Biosciences is Hosting KOL Meeting on Subcutaneous Factor-VIIa Marzeptacog Alfa (Activated) in Bleeding Disorders Patients on 15 August BіоPhаrmа Dіvе
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment